Active ingredientGanaxoloneCat. No. P-G015-001CAS 38398-32-2Family · Pharmaceutical analytical standards
Ganaxolone
A synthetic neurosteroid, an analogue of allopregnanolone, that enhances GABA-A receptors: approved in the United States in March 2022 and in the European Union in July 2023 for seizures in CDKL5 deficiency disorder. This family brings together the active ingredient and other impurities.
Did you know?Compared with its natural model, allopregnanolone, it carries one extra methyl group at position 3β, and it has no known hormonal activity.
Go to the active ingredient →Active ingredientGanaxoloneCat. No. P-G015-001CAS 38398-32-2
ImpurityGanaxolone Impurity 1Cat. No. P-G015-002CAS 1264737-31-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.